SEC Filing 8-K: Dova Pharmaceuticals, Inc.
November 28, 2017 8:25am EST
Source: SEC (Index ) via Sqoop
- § Other Events;
- § Financial Statements and Exhibits;
99.1 Press Release titled Dova Pharmaceuticals Announces FDA Acceptance of the Avatrombopag New Drug Application (NDA) with Priority Review dated November 27, 2017.